Concurrent Chemoradiation Therapy With or Without Nimotuzumab in Locally Advanced Squamous Cell Lung Cancer: A Phase 2 Randomized Trial-Reference-Cited by-同舟云学术

Concurrent Chemoradiation Therapy With or Without Nimotuzumab in Locally Advanced Squamous Cell Lung Cancer: A Phase 2 Randomized Trial

Published:2021-11 Issue:4 Volume:111 Page:917-925
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Qiu Bo,Wang DaQuan,Li QiWen,Wu YingJia,Guo SuPing,Jiang XiaoBo,Fang JianLan,Guo JinYu,Liu FangJie,Chu Chu,Wang Bin,Chen Li,Zhang Jun,Liu YiMei,Hu YongHong,Liu Hui^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference34 articles.

1. Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: A multicenter randomized phase III trial;Liang;Ann Oncol,2017

2. Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023;Kelly;J Clin Oncol,2008

3. Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: A secondary analysis of the NRG Oncology RTOG 0617 randomized clinical trial;Chun;J Clin Oncol,2017

4. Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer;Paz-Ares;N Engl J Med,2018

5. Atezolizumab in combination with carboplatin and nab-paclitaxel in advanced squamous NSCLC (IMpower131): Results from a randomized phase III trial;Jotte;J Thorac Oncol,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nimotuzumab combined with radiotherapy+/- chemotherapy for definitive treatment of locally advanced squamous cell carcinoma of head and neck: a metanalysis of randomized controlled trials;Frontiers in Oncology;2024-06-13

2. Recent advances progress of targeted drugs combined with radiotherapy for advanced non-small cell lung cancer: a review;Frontiers in Oncology;2023-12-05

3. Hypofractionated Radiotherapy followed by Hypofractionated Boost with weekly concurrent chemotherapy for Unresectable Stage III Non–Small Cell Lung Cancer: Results of A Prospective Phase II Study (GASTO-1049);International Journal of Radiation Oncology*Biology*Physics;2023-10

4. A Meta Analysis of the Efficacy and Safety of Nimotuzumab Combined with Radiotherapy or Chemotherapy in the Treatment of Non-Small Cell Lung Cancer;Advances in Clinical Medicine;2023

5. Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients;Frontiers in Oncology;2022-11-18